Business
Dexcom and Insulet Announce Commercial Agreement to Integrate the Dexcom G6 and Future G7 CGM into Insulet’s Omnipod Horizon™ Automated Insulin Delivery System
First-ever automated insulin delivery with the tubeless Omnipod Insulin Management System and personal smartphone control Initially compatible with Dexcom G6
About this update from Dexcom, Inc.
[{"type":"text","content":"\n\nFirst-ever automated insulin delivery with the tubeless Omnipod Insulin Management System and personal smartphone control\n\n\nInitially compatible with Dexcom G6 CGM, with no fingersticks* required\n\n\nIntegration with the next generation Dexcom G7 CGM system, once available\n\n\n SAN DIEGO & ACTON, Mass.--(BUSINESS WIRE)--\nDexCom, Inc. (NASDAQ: DXCM) and Insulet Corporation (NASDAQ: PODD), have announced a global commercialization agreement to combine current and future Dexcom continuous glucose monitoring systems (CGM) with Insulet’s trusted tubeless insulin delivery Pod into the Omnipod Horizon™ System for automated insulin delivery, currently in pivotal trial. Under the terms of the non-exclusive agreement, the Omnipod Horizon Automated Insulin Delivery (AID) System will use sensor values from the Dexcom G6 and next generation G7 CGM systems to predict glucose levels into the future and automatically adjust the insulin dose required to help reduce the occurrence of blood glucose highs and lows.\n\n\n“Everyone at Dexcom is excited to be in the final stages of integrating Dexcom CGM technology into the Omnipod Horizon System,\" said Kevin Sayer, executive chairman, president and CEO of Dexcom. \"This system will bring together the demonstrated accuracy of Dexcom CGM with Omnipod’s tubeless insulin delivery Pod which provides a simple user experience and freedom from injections and tubes. It will be a truly transformative, automated insulin delivery system giving more options to people with diabetes.”\n\n\n“This agreement with Dexcom represents an incredible milestone for our two organizations in realizing the benefits of interoperability,” said Shacey Petrovic, president and CEO of Insulet. “The ability to integrate with new innovation efficiently will offer consumers the latest and greatest in Pod and sensor technology, while providing the freedom of choice so they can live life to the fullest.”\n\n\nThe Omnipod Horizon System will combine market leading technologies into one integrated system consisting of the Omnipod tubeless insulin delivery Pod, the Dexcom CGM, and for the first time, an insulin pump controlled by the convenience of one’s personal smartphone.\n\n\nWith Dexcom CGM integration, the Omnipod Horizon System requires no fingersticks* for blood glucose measurement or CGM calibration and will feature an ex...